EV046120

EV046120 is a human monoclonal antibody developed by Evec, a Japanese biotechnology company specializing in the discovery of human antibodies from peripheral blood B cells. The antibody is designed to act as a neutralizing agent against human metapneumovirus (hMPV) and respiratory syncytial virus (RSV). By targeting viral surface antigens, EV046120 aims to prevent viral attachment and entry into host respiratory epithelial cells, potentially offering a therapeutic or prophylactic approach to these common respiratory infections. While mentioned in Evec's early pipeline disclosures (circa 2014), the specific clinical development status of EV046120 is currently unclear, and it may have been integrated into the company's broader hMPV/RSV therapeutic programs.